Full Press Release Details
CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will participate in the following upcoming healthcare conferences in September:
Tuesday, September 4, 2018
B. Riley FBR Healthcare Conference
Panel: A Beginner’s Guide to Gene Therapy
Location: New York, NY
Wednesday, September 5, 2018
Citi Biotech Conference
Location: Boston, Massachusetts
Thursday, September 6, 2018
Wells Fargo Healthcare Conference
Location: Boston, Massachusetts
Thursday, September 27, 2018
Jefferies Gene Therapy Summit
Location: New York, NY
A live webcast of Intellia’s participation on the panel at the Citi Biotech Conference and presentation at the Wells Fargo Healthcare Conference will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.
About Intellia Therapeutics
Vice President, Investor Relations
Jennifer Mound Smoter
Senior Vice President, External Affairs & Communications